Califf Nomination For FDA Commish Could Reflect Bipartisan Appeal
This article was originally published in The Rose Sheet
Executive Summary
After seven months as deputy commissioner for medical products and tobacco, Robert Califf has been tapped for FDA Commissioner.
You may also be interested in...
Oral History Of Drug Development: FDA’s Califf Wants Woodcock, Temple To Share Their Stories
In an interview with “The Pink Sheet,” new deputy commissioner for medical products says FDA needs better ways of helping stakeholders, public understand agency thinking.
FDA Staying The Course Under Ostroff; Hamburg’s Concerns Will Remain Focus
Acting FDA Commissioner says he can’t envision any new major priorities that would emerge in the short-term.
FDA Lands Califf As Top Deputy, Potential Next Commissioner
Renowned cardiologist and clinical trial researcher Robert Califf will join FDA in February as deputy commissioner for medical products and tobacco. Califf is director of Duke University’s Translational Medicine Institute and vice chancellor for Clinical and Translational Research.